The present invention provides novel polynucleotides encoding CAN-12 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants of CAN-12 polypeptides, CAN-12v1 and CAN-12v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel CAN-12, CAN-12v1, and CAN-12v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly neuro- and musculo-degenerative conditions. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
本发明提供了编码 CAN-12
多肽、其片段和同源物的新型多
核苷酸。本发明还提供了编码 CAN-12
多肽变体 CAN-12v1 和 CAN-12v2 的多
核苷酸。本发明还提供了生产上述
多肽的载体、宿主细胞、
抗体以及
重组和合成方法。本发明进一步涉及将这些新型 CAN-12、CAN-12v1 和 CAN-12v2
多肽应用于诊断、治疗和/或预防与这些
多肽相关的各种疾病和/或失调的诊断和治疗方法,特别是神经和肌肉退行性疾病。本发明进一步涉及鉴定本发明多
核苷酸和
多肽的激动剂和
拮抗剂的筛选方法。